TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $580 | +35.5% | 37,477 | +37.7% | 0.01% | +28.6% |
| Q2 2023 | $428 | +2.9% | 27,222 | +7.9% | 0.01% | 0.0% |
| Q1 2023 | $416 | -99.9% | 25,221 | +5.3% | 0.01% | 0.0% |
| Q4 2022 | $374,000 | -99.9% | 23,953 | +17.2% | 0.01% | +40.0% |
| Q3 2022 | $265,000,000 | +98048.1% | 20,446 | +6.2% | 0.01% | 0.0% |
| Q2 2022 | $270,000 | +21.1% | 19,249 | +23.9% | 0.01% | +25.0% |
| Q1 2022 | $223,000 | -99.9% | 15,541 | +22.9% | 0.00% | +33.3% |
| Q4 2021 | $172,000,000 | +84629.1% | 12,648 | +2.3% | 0.00% | -25.0% |
| Q3 2021 | $203,000 | -5.1% | 12,368 | -2.6% | 0.00% | -20.0% |
| Q2 2021 | $214,000 | -5.3% | 12,704 | +2.8% | 0.01% | 0.0% |
| Q1 2021 | $226,000 | +14.7% | 12,360 | +14.2% | 0.01% | 0.0% |
| Q4 2020 | $197,000 | – | 10,821 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |